MARKET

CSII

CSII

Cardiovascular
NASDAQ
13.98
-0.45
-3.12%
After Hours: 13.98 0 0.00% 16:02 10/05 EDT
OPEN
14.15
PREV CLOSE
14.43
HIGH
14.37
LOW
13.70
VOLUME
174.40K
TURNOVER
0
52 WEEK HIGH
36.97
52 WEEK LOW
12.51
MARKET CAP
585.84M
P/E (TTM)
-14.8518
1D
5D
1M
3M
1Y
5Y
Cardiovascular Systems (CSII) Q4 Earnings, Revenues Miss Mark
According to Cardiovascular Systems (CSII), strong sequential growth in each of its segments is due to procedure recovery, focused commercial strategies and the launch of products.
Zacks · 08/08 13:09
Cardiovascular Systems Widens Fiscal Q4 Net Loss as Revenue Falls; Issues Fiscal 2023 Outlook; Shares Gain
Cardiovascular Systems Widens Fiscal Q4 Net Loss as Revenue Falls; Issues Fiscal 2023 Outlook; Shares Gain
MT Newswires · 08/03 14:12
Cardiovascular Systems reports Q4 earnings miss; provides FY23 revenue guidance in-line with estimates
Cardiovascular Systems press release (<span ...
Seekingalpha · 08/03 04:19
Cardiovascular Systems Posts Wider Fiscal Q4 Loss as Revenue Declines
Cardiovascular Systems Posts Wider Fiscal Q4 Loss as Revenue Declines
MT Newswires · 08/03 03:21
BRIEF-Cardiovascular Systems, Inc Reports Fourth-Quarter Net Loss Of $9.7 Million, Or $0.25 Per Basic And Diluted Share
BRIEF-Cardiovascular Systems, Inc Reports Fourth-Quarter Net Loss Of $9.7 Million, Or $0.25 Per Basic And Diluted Share
Reuters · 08/03 00:32
Shareholders in Cardiovascular Systems (NASDAQ:CSII) are in the red if they invested a year ago
Even the best stock pickers will make plenty of bad investments. And unfortunately for Cardiovascular Systems, Inc...
Simply Wall St. · 07/04 11:12
QuidelOrtho (QDEL) Stock Jumps 3.9%: Will It Continue to Soar?
QuidelOrtho (QDEL) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might not help the stock continue moving higher in the near term.
Zacks · 06/20 12:59
Cardiovascular Systems chief operating officer Rhonda Robb exits company
Cardiovascular Systems (NASDAQ:CSII) said on Tuesday its chief operating officer Rhonda Robb's employment with the company had ended on Monday. The company said in a form 8-K filing on Tuesday. The company said
Seekingalpha · 06/07 21:04
More
About CSII
Cardiovascular Systems, Inc. is a medical technology company. The Company is engaged in treating patients suffering from peripheral and coronary artery diseases, including those with arterial calcium. The Company has developed orbital atherectomy systems (OAS) for both peripheral and coronary clinical applications. The primary base of its business is catheter-based platforms capable of treating a range of vessel sizes and plaque types, including calcified plaque. Its peripheral artery disease (PAD) products are catheter-based platforms capable of treating a range of plaque types in leg arteries both above and below the knee, including calcified plaque. Its coronary artery disease (CAD) product, the Diamondback 360 Coronary OAS (Coronary OAS), is a catheter-based platform designed to facilitate stent delivery in patients with CAD who are acceptable candidates for percutaneous transluminal coronary angioplasty or stenting due to de novo, severely calcified coronary artery lesions.

Webull offers kinds of Cardiovascular Systems Inc stock information, including NASDAQ:CSII real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, CSII stock news, and many more online research tools to help you make informed decisions.

You can practice and explore trading CSII stock methods without spending real money on the virtual paper trading platform.